Announcements Trials

Browse Landscape

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Carcinoma, Non-Small-Cell Lung 23 Squamous Cell Carcinoma of Head and Neck 10 Melanoma 8 Lung Neoplasms 8 Neoplasms 7 Carcinoma 6 Skin Neoplasms 5 Neoplasm Metastasis 5 Carcinoma, Squamous Cell 5 Carcinoma, Basal Cell 5 Adenocarcinoma 5 Mouth Neoplasms 4 Head and Neck Neoplasms 4 Colonic Neoplasms 4 Carcinoma, Renal Cell 4 Urinary Bladder Neoplasms 3 Sarcoma 3 Oropharyngeal Neoplasms 3 Laryngeal Neoplasms 3 Carcinoma, Merkel Cell 3 Breast Neoplasms 3 Triple Negative Breast Neoplasms 2 Recurrence 2 Rectal Neoplasms 2 Pancreatic Neoplasms 2 Mesothelioma, Malignant 2 Hemangiosarcoma 2 Colorectal Neoplasms 2 Carcinoma, Hepatocellular 2 Adrenocortical Carcinoma 2

Interventions

pembrolizumab 5 Nivolumab 4 Cisplatin 4 Paclitaxel 3 Ifosfamide 3 avelumab 2 aldesleukin 2 Radiotherapy 2 Magnetic Resonance Spectroscopy 2 Ipilimumab 2 vinflunine 1 toripalimab 1 rocakinogene sifuplasmid 1 niraparib 1 nimotuzumab 1 lenvatinib 1 fludarabine phosphate 1 fludarabine 1 enfortumab vedotin 1 durvalumab 1 dostarlimab 1 dacomitinib 1 cemiplimab 1 cabozantinib 1 cabazitaxel 1 Vorinostat 1 VGX-3100 1 Specimen Handling 1 Ritonavir 1 Neoadjuvant Therapy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Penile Neoplasms × cemiplimab × Clear all

NCT07101822 2025-08-03

BRAVA PENILE

Hospital Israelita Albert Einstein

Phase 2 Not yet recruiting

Penile Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡